| Operating Cash Flow |
-$129.79M |
-$194.41M |
-$193.31M |
-$90.81M |
| -Change in Other Current Assets |
$0.00 |
-$3.67M |
$0.00 |
-$1.32M |
| -Change in Payables and Accrued Expense |
-$7.66M |
$53.79M |
$28.18M |
$6.92M |
| -Change in Prepaid Assets |
$1.40M |
$2.98M |
-$10.29M |
$407,000.00 |
| -Change in Receivables |
$243,000.00 |
$358,000.00 |
-$521,000.00 |
$621,000.00 |
| Change in Working Capital |
-$7.61M |
$52.05M |
$15.35M |
$3.86M |
| Other Non-Cash Items |
$4.24M |
$3.96M |
$5.03M |
$1.62M |
| Depreciation & Depletion & Amortization |
$2.48M |
$2.29M |
$1.19M |
$1.23M |
| Gain/Loss from Continuing Operations |
$12,000.00 |
-$2.00B |
$1.64M |
$19,000.00 |
| Net Income from Continuing Operations |
-$140.06M |
$1.69B |
-$241.36M |
-$115.33M |
| Net cash flow from continuing operations |
-$129.79M |
-$194.41M |
-$193.31M |
-$90.81M |
| -Change in Other Current Liabilities |
-$1.60M |
-$1.41M |
-$1.86M |
-$1.67M |
| Net cash flow from investing |
-$28,000.00 |
-$2.60M |
-$4.59M |
-$686,000.00 |
| Free Cash Flow |
-$129.83M |
-$197.01M |
-$197.90M |
-$91.50M |
| Beginning Cash Balance |
$152.60M |
$277.92M |
$273.87M |
$0.00 |
| Net Change in Cash |
-$28.38M |
-$125.33M |
$4.06M |
– |
| Ending Cash Balance |
$124.22M |
$152.60M |
$277.92M |
$0.00 |
| Net Other Financing Charges |
-$125,000.00 |
– |
-$355,000.00 |
$91.50M |
| Proceeds from Stock Option Exercised |
$1.61M |
$71.68M |
$2.32M |
– |
| Net Issuance Payments Of Debt |
$99.97M |
$0.00 |
– |
– |
| Net Cash Flow from Continuing Financing Activities |
$101.45M |
$71.68M |
$201.96M |
$91.50M |
| Financing Cash Flow |
$101.45M |
$71.68M |
$201.96M |
$91.50M |
| Net PPE Purchase and Sale |
-$28,000.00 |
-$2.60M |
-$4.59M |
-$686,000.00 |
| Net Cash Flow from Continuing Investing Activities |
-$28,000.00 |
-$2.60M |
-$4.59M |
-$686,000.00 |
| -Change In Other Working Capital |
– |
– |
-$166,000.00 |
-$1.10M |
| Net Common Stock Issuance |
– |
– |
$200.00M |
– |
No comments yet — be the first to weigh in on INBX.